Testing effectiveness (Phase 2)Ended earlyNCT03875313
What this trial is testing
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors
Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaTNBC - Triple-Negative Breast Cancer+4 more
Calithera Biosciences, Inc 33